Trial intelligence / Profile preview

MultiHance vs Omniscan in Brain MRI (ENHANCE)

NCT00323102Phase 4Completed

Sponsor
Bracco Diagnostics Inc.
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gadobenate dimeglumine in brain tumor, sponsored by Bracco Diagnostics Inc.. Started May 2006; status: completed.

02

Drugs

gadobenate dimeglumine
03

Conditions

brain tumor

Beyond the preview

Go deeper on NCT00323102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00323102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call